Arterial Inflammation and Coronary Microvascular Dysfunction among Women with HIV: Missing Pieces to the MI Risk Puzzle

女性艾滋病毒感染者的动脉炎症和冠状动脉微血管功能障碍:心肌梗死风险之谜中的缺失部分

基本信息

  • 批准号:
    10231141
  • 负责人:
  • 金额:
    $ 83.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-09 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

7. Project Summary/Abstract In the US, nearly half of the 1.1 million people with HIV (PHIV) are aged 50 and older. This aging HIV population is uniquely vulnerable to select cardiovascular (CV) comorbidities, including myocardial infarction (MI). Women with HIV (WHIV) face the highest HIV-attributable risk of MI: a 3-fold increased risk vs. non-HIV- infected women. Given the public health impact of MI-related morbidity and mortality, strong imperatives exist to better understand mechanisms underlying MI risk among WHIV. Characterization of pathways predisposing WHIV to MI will enable the development of rational MI prevention strategies and the targeted delivery of such strategies to women in need. Through this proposal, our interdisciplinary team will combine state-of-the-art non-invasive CV imaging with detailed molecular immune cell and endothelial cell phenotyping to define mechanisms predisposing WHIV to MI. Studying a prospectively recruited cohort of WHIV vs. non-HIV-infected women, we will explore a well-substantiated central hypothesis: Among women, HIV infection prompts systemic monocyte activation and endothelial cell pathology, predisposing to increased arterial inflammation. Arterial inflammation and endothelial cell pathology, in turn, promote not only non-calcified epicardial artery plaque but also coronary microvascular dysfunction. We plan to show that arterial inflammation and coronary microvascular dysfunction represent thus far neglected but potentially critical mechanisms of HIV-attributable MI risk among women – missing puzzle pieces (Aims 1-2). We also aim to delineate - on a molecular level - how circulating monocyte and vascular endothelial cell phenotypes differ among WHIV vs. non-HIV-infected women. Finally, we will investigate how pathologic monocyte/endothelial cell phenotypes may engender arterial inflammation, non-calcified epicardial artery plaque, and/or coronary microvascular dysfunction among WHIV (Aim 3). Confirmation of our central hypothesis will introduce a paradigm-shift in conceptualizing HIV- attributable MI risk among women – focused not only on macroscopic atherosclerotic plaque in the epicardial arteries but also on arterial inflammation and coronary microvascular dysfunction. Moreover, our work on mechanistic pathways engendering CV pathology among WHIV will inform the design of future research in the field. Specifically, we anticipate our work will suggest that strategies to mitigate monocyte honing to the vasculature (e.g. CCR2 blockade) or strategies to improve vascular endothelial cell function (e.g. metformin) should be tested for ability to forestall or reverse the key pathologic processes driving MI risk among WHIV. Further, our work will enable future studies on cardioprotective interventions among WHIV to be powered to the most appropriate CV surrogate risk endpoints – those which are found in this study to differ most strikingly among women with vs. without HIV. As MI is a highly-morbid, age-related comorbidity to which WHIV are particularly vulnerable, our work will have significant implications to improve cardiovascular disease prevention among at-risk women aging with HIV.
7. 项目总结/摘要 在美国,110 万艾滋病毒 (PHIV) 感染者中近一半年龄在 50 岁及以上。这种老化的艾滋病毒 人群特别容易罹患某些心血管 (CV) 合并症,包括心肌梗塞 (MI)。感染艾滋病毒 (WHIV) 的女性面临最高的艾滋病毒所致 MI 风险:与非艾滋病毒女性相比,风险增加 3 倍 受感染的妇女。鉴于心肌梗死相关发病率和死亡率对公共卫生的影响,迫切需要采取措施 更好地了解 WHIV 中 MI 风险的潜在机制。诱发途径的特征 将 WHIV 转化为 MI 将有助于制定合理的 MI 预防策略并有针对性地提供此类治疗 向有需要的妇女提供的策略。通过这项提案,我们的跨学科团队将结合最先进的技术 无创 CV 成像,通过详细的分子免疫细胞和内皮细胞表型来定义 WHIV 诱发 MI 的机制。研究前瞻性招募的 WHIV 与非 HIV 感染者队列 对于女性,我们将探索一个得到充分证实的中心假设:在女性中,艾滋病毒感染提示 全身单核细胞活化和内皮细胞病理学,易导致动脉炎症增加。 动脉炎症和内皮细胞病理反过来不仅促进心外膜动脉的非钙化 斑块还可能导致冠状动脉微血管功能障碍。我们计划证明动脉炎症和冠状动脉 微血管功能障碍代表了迄今为止被忽视但可能是艾滋病毒归因的关键机制 女性心梗风险——缺失的拼图(目标 1-2)。我们还旨在在分子水平上描绘- WHIV 与非 HIV 感染者之间的循环单核细胞和血管内皮细胞表型有何不同 女性。最后,我们将研究病理性单核细胞/内皮细胞表型如何产生 动脉炎症、非钙化心外膜动脉斑块和/或冠状动脉微血管功能障碍 WHIV(目标 3)。我们的中心假设的证实将带来艾滋病毒概念的范式转变 女性的心肌梗死风险——不仅关注心外膜的宏观动脉粥样硬化斑块 动脉还与动脉炎症和冠状动脉微血管功能障碍有关。此外,我们的工作 WHIV 中引起 CV 病理学的机制途径将为未来研究的设计提供信息 场地。具体来说,我们预计我们的工作将提出减轻单核细胞磨削的策略 血管系统(例如 CCR2 阻断)或改善血管内皮细胞功能的策略(例如二甲双胍) 应测试预防或逆转 WHIV 中导致 MI 风险的关键病理过程的能力。 此外,我们的工作将使未来关于 WHIV 心脏保护干预措施的研究能够 最合适的心血管替代风险终点——本研究中发现的差异最显着的终点 感染艾滋病毒的女性与未感染艾滋病毒的女性之间的比较。由于 MI 是一种发病率很高、与年龄相关的合并症,WHIV 是其中之一 特别容易受到伤害,我们的工作将对改善心血管疾病的预防产生重大影响 感染艾滋病毒的高危女性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Markella V. Zanni其他文献

Meal replacement therapy for obesity and diabetes remission: efficacy assessment and considerations of barriers and facilitators to adherence among U.S. individuals with low economic resources
  • DOI:
    10.1007/s11154-024-09925-6
  • 发表时间:
    2024-11-18
  • 期刊:
  • 影响因子:
    8.000
  • 作者:
    Claudia G. Durbin;Ainsley Hutchison;Talia Colecchi;Jennifer Mulligan;Sreevidya Bodepudi;Markella V. Zanni;Chika Vera Anekwe
  • 通讯作者:
    Chika Vera Anekwe
RITONAVIR-BASED ANTI-RETROVIRAL THERAPY IS ASSOCIATED WITH A LOWER EJECTION FRACTION AND AN INCREASED RISK FOR DECOMPENSATED HEART FAILURE AND CARDIOVASCULAR MORTALITY AMONG PERSONS LIVING WITH HIV
  • DOI:
    10.1016/s0735-1097(18)31424-4
  • 发表时间:
    2018-03-10
  • 期刊:
  • 影响因子:
  • 作者:
    Raza M. Alvi;Anne M. Neilan;Noor Tariq;Magid Awadalla;Dahlia Banerji;Adam Rokicki;Virginia Triant;Markella V. Zanni;Tomas Neilan
  • 通讯作者:
    Tomas Neilan
Risk of coronary heart disease in patients with HIV infection
艾滋病患者患冠心病的风险
  • DOI:
    10.1038/nrcardio.2014.167
  • 发表时间:
    2014-10-21
  • 期刊:
  • 影响因子:
    44.200
  • 作者:
    Markella V. Zanni;Judith Schouten;Steven K. Grinspoon;Peter Reiss
  • 通讯作者:
    Peter Reiss
Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: emJACC: CardioOncology/em State-of-the-Art Review
免疫检查点抑制剂治疗相关动脉粥样硬化:证据、诊断和管理:emJACC:心血管肿瘤学/最先进的综述
  • DOI:
    10.1016/j.jaccao.2022.11.011
  • 发表时间:
    2022-12-01
  • 期刊:
  • 影响因子:
    12.800
  • 作者:
    Giselle Alexandra Suero-Abreu;Markella V. Zanni;Tomas G. Neilan
  • 通讯作者:
    Tomas G. Neilan

Markella V. Zanni的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Markella V. Zanni', 18)}}的其他基金

Consequences of Persistent Immune Activation among ART-treated Women with HIV
接受抗逆转录病毒治疗的艾滋病毒女性持续免疫激活的后果
  • 批准号:
    10669637
  • 财政年份:
    2021
  • 资助金额:
    $ 83.33万
  • 项目类别:
Consequences of Persistent Immune Activation among ART-treated Women with HIV
接受抗逆转录病毒治疗的艾滋病毒女性持续免疫激活的后果
  • 批准号:
    10456954
  • 财政年份:
    2021
  • 资助金额:
    $ 83.33万
  • 项目类别:
Consequences of Persistent Immune Activation among ART-treated Women with HIV
接受抗逆转录病毒治疗的艾滋病毒女性持续免疫激活的后果
  • 批准号:
    10161223
  • 财政年份:
    2021
  • 资助金额:
    $ 83.33万
  • 项目类别:
Arterial Inflammation and Coronary Microvascular Dysfunction among Women with HIV: Missing Pieces to the MI Risk Puzzle
女性艾滋病毒感染者的动脉炎症和冠状动脉微血管功能障碍:心肌梗死风险之谜中的缺失部分
  • 批准号:
    10453446
  • 财政年份:
    2019
  • 资助金额:
    $ 83.33万
  • 项目类别:
Effects of TNF-a Antagonism in Patients with Obesity and Metabolic Dysregulation
TNF-α 拮抗剂对肥胖和代谢失调患者的影响
  • 批准号:
    8094345
  • 财政年份:
    2010
  • 资助金额:
    $ 83.33万
  • 项目类别:
Effects of TNF-alpha Antagonism in Patients with Obesity and Metabolic Dysregulat
TNF-α拮抗剂对肥胖和代谢失调患者的影响
  • 批准号:
    7803389
  • 财政年份:
    2010
  • 资助金额:
    $ 83.33万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 83.33万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 83.33万
  • 项目类别:
    Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 83.33万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 83.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 83.33万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 83.33万
  • 项目类别:
    Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 83.33万
  • 项目类别:
    Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 83.33万
  • 项目类别:
    Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
  • 批准号:
    498278
  • 财政年份:
    2024
  • 资助金额:
    $ 83.33万
  • 项目类别:
    Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
  • 批准号:
    24K04938
  • 财政年份:
    2024
  • 资助金额:
    $ 83.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了